Despite being among the world’s leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countries for the purchase of essential scientific-related products. Is this sustainable? Therefore it is necessary to draw the attention of all the world and Brazilian society about this situation

尽管巴西在科学产出方面位居世界领先地位，但其最先进科学分析所需试剂和用品的生产量在各国中排名第 66 位。巴西国内严重缺乏用于实验分析和患者诊断所需试剂和设备的生产，在 SARS-CoV-2 引起的大流行期间尤为如此。巴西资助机构的很大一部分资源现在正在转移给其他国家的公司，用于购买重要的科学相关产品。这是可持续的吗？因此，这一情况有必要引起全世界和巴西社会的关注。